First, need more info about results, how significant of the benefits or the chance this can go through phase iii.
Then the big question, if this go through all the way and approved, what would be the fair valuation?
It is all about the revenue, so what number will justify the market Cap at 145 million ( correspond to how many products per month)?
Stock up and down all the time, nothing goes straight. So sooner or later at some time there wii be pull back, 15-30% easy. On the other hand , eventually PPS which represents the market value will close to the bottom-line, so what will be the bottom-line of MCIG in the 2014?
Last reported revenue is around 13K/month and today's market Cap is around 145 million!
So long way to go
No question no argument huge potential. So reality current price fair, too high too low?
Fundamentally how long before next major catalyst? Revenue, cash enough for xx months before need fresh funding?
Technically, recently pull back is healthy for sure, couple of weeks consolidation is always necessary after PPS double or triple in a short period of time, of course the tricky is when and at what price, could happen now or after another great run to close to $ sign.
How many here are true longs and will hold for the phase III? Many taking about abstract, accept or not has nothing to with the success trials but only for P&D of stock price.
Any "assumption" about value of this company with or without MJ business? Think CEO will comment on this?
Only one way stock?
Long term based on the clinical trial results which nobody has control, if positive, then $20 possible, if bad? Short term, expect profits taking for sure this week, could be at current price or above $10.
The key is not to make "big" money, it is to make a decision that most likely to make money not lee money.
If only consider to make big money, most likely will turns out lose big.
So, let it set down wait for Monday at least . IMO
Business is one thing, sometimes nobody can control, war, storm, politic etc, mgmt is another . MCIG CEO looks like really cares retail investors. He " donates" his own share to avoid dilution vs PHOT issue billion new shares